|
Richard John Torrens |
|
||||||||
| Dorset holiday | DIY & Electronics | Family History | Hi-Fi History | Misc | Natural History | Wild Food | Walks | |||
| Prof. Hugh Torrens | Biography | Books | Medical | Cats | Dorset holiday | Walks etc. in Dorset | Old Photos | |||
After a lifetime of "acid tummy" (my story) I was dIagnosed with a long segment Barrett's. But PPIs caused me problems which made me stop PPIs and gave me a strong need to seek explanation. Several years of hunting technical papers on the www confirmed something I was initially loathe to believe.
There is a lot of circumstantial evidence that PPI use and oesophageal adenocarcinoma (OAC) are linked, but it has been unclear as to what is causing them both. However good evidence exists in the published papers to prove that PPIs themselves are the (indirect) cause of the increasing OAC!
It is also worthy of note that PPIs are prescribed far too freely for almost any eating problem - especially in the elderly. My mother wasn't eating properly so was given PPIs. The real problem was that she needed new false teeth!
Of course I cannot deny that PPIs can, used properly, be instrumental in reducing problems that can lead to cancer. But do PPIs cure more cancer than they cause? See my page of references to papers that link PPIs to various cancers.
Proton pump inhibitors reduce gall bladder function is the follow-up to the above paper. The authors realised the effects might be due to PPIs so tested 19 volunteers before and after a course of PPIs. 15 of the volunteers had reduced gall bladder function after taking PPIs. In other words PPIs cause Biliary dyskinesia (link is to refs to medical papers) in most of the people tested. The test was done by using cholestocystokynin, the hormone the body uses to trigger bile release.
The test was done by giving the volunteers 40mg per day. It may be that other dosages do not have the same effect - although my own experiments with omeprazole would seem to indicate almost any dosage is a potential problem.
This research, which should have rung an alarm bell, seems to have never been followed up. Unfortunately the test was done on only a small sample, but a high result on a small sample is very indicative. Large samples are usually used on medical research because the effects that might be present are difficult to test. The small sample size has made it possible for the medical profession to dismiss the study. I smell a case of If you don't want to know the answer - don't do the experiment!
This is the only step in the process that isn't document in medical literature. However there is one paper where gastric fluid was measured and PPI users were compared with non-users. The authors compared 25 patients on PPIs with 40 not on PPIs. It found "Of particular interest were substantial differences in the concentrations of digestive enzymes between the two pools). Most (14 of 16) of the pancreatic or hepatic enzymes identified were elevated in patients on PPIs." This elevation includes bile and trypsin, a pancreatic enzyme. So although the process isn't documented, it is quite clear that it happens. See my list of references for more comments.
A paper in 2016 entitled entitled Maintenance proton pump inhibition therapy and risk of oesophageal cancer was published. Its results: "Among all individuals using maintenance PPI therapy, the overall SIR of oesophageal adenocarcinoma was 3.93". SIR is Standardised Incidence Ratio - which is the the ratio of the results obtained divided by the expected results. In other words the chances of progression found in this study of 796,492 adults are nearly four times higher for PPI users than for non users.
See my page of references for other indicative papers. There is plenty more on the subject, see the site index.
a the time of writing this (December, 2016), there are still a few slightly possible problems in the assumption that bile, released at the wrong time, will get into the stomach.
9th of December, 2022. This is answered by the fact that hypergastrinemia caused by PPIs alo affects the sphincter of Oddi. See the Afterword
The hormones in the digestive system time bile release to occur when chyme (food which has been processed in the stomach) is passing through the pyloric sphincter. It is evolved for one direction of flow of semi-solid chyme. I think it highly unlikely it can resist back-flow of bile!
However WebMD states the associated symptoms of dyskinesia should include: ... bitter taste in the mouth. In other words - bile reflux!
Further evidence that such bile reflux does occur is explained in my own experiments with PPIs.
One theory is that bile is absolutely necessary for Barrett's to form. In practise, proving a negative in science is close to impossible. So to prove Barrett's cannot form without bile is a problem. Statistical evidence could be accumulated if gastric fluid samples were regularly screened for bile. They are not! But this is beside the point: gastric bile is clearly more dangerous than untainted fluid. Occasional tainting may indeed occur. But regularly tainted gastric fluid is clearly dangerous.
PPIs should in theory become less effective with time as tolerance develops. I am aware of no experiments on this matter.
You will get a list of links which find exactly that. PPIs are known to cause hypergastrinemia. Gastrin is one of the chief digestive hormones. Secretion of gastrin is inhibited when gastric acidity rises. PPIs stop the secretion of stomach acid, so gatrin levels do not drop properly,
Hypergastrinemia is linked to cancer. Not only oesohageal but gastric and even, possibly, colonic. The papers turned up by the search prove that.
One of the things gastrin controls is the sphicter of Oddi - which releases bile from the gall bladder.
Need I say more?
Was this page helpful? Please email me and/or rate this page:
  |